Opus Genetics, Inc. Current Assets
Opus Genetics, Inc. (IRD) had Current Assets of $92.70 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $92.70M.
- 2026-03-31: Assets, Current $66.60M.
- 2025-12-31: Assets, Current $50.04M.
- 2025-09-30: Assets, Current $35.91M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $92.70M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $66.60M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $50.04M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $35.91M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $38.44M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $47.93M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $36.61M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $40.39M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $44.83M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $51.84M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $53.95M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $54.19M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $43.46M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $45.40M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $48.99M 10-K · filed 2024-03-08 | |
| 2022-09-30 | $14.56M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $17.89M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $20.48M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $26.07M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $23.19M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $25.24M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $12.11M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $17.67M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $8.65M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $10.03M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $11.29M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.76M 10-K · filed 2021-03-11 | $12.66M 10-K · filed 2020-02-21 |
| 2019-09-30 | $14.64M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $17.29M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $18.99M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $15.90M 10-K · filed 2020-02-21 | |
| 2018-09-30 | $13.72M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $18.11M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $22.41M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $28.14M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $24.48M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $27.98M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $19.47M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $20.92M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $22.61M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $20.39M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $25.41M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $24.66M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $22.93M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $27.26M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $30.38M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $33.43M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $36.34M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $39.11M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $40.90M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $19.30M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $15.49M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $10.47M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $12.35M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $13.78M 10-K · filed 2014-03-21 | |
| 2012-09-30 | $7.70M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $8.92M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $10.35M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $12.16M 10-K · filed 2013-03-22 | |
| 2011-09-30 | $15.65M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $18.59M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $15.67M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |